Rifaximin SSD in Dementia Trial
Rifaximin SSD in Dementia Trial
Recruiting · NCT06718686 · Registry updated 2026-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rifaximin SSD in Dementia Trial | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-03 | NCT06718686 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bausch Health Americas, Inc. | 23 |
| Jasmohan Bajaj | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Richmond VA Medical Center | Richmond | United States | 10 |